- Home
- ELVN vs BAK Comparison
ELVN vs BAK Comparison
Compare ELVN & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- BAK
- Stock Information
- Founded
- ELVN 2016
- BAK 1972
- Country
- ELVN United States
- BAK Brazil
- Employees
- ELVN N/A
- BAK N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- ELVN Health Care
- BAK Industrials
- Exchange
- ELVN Nasdaq
- BAK Nasdaq
- Market Cap
- ELVN 1.2B
- BAK 952.4M
- IPO Year
- ELVN 2020
- BAK N/A
- Fundamental
- Price
- ELVN $20.52
- BAK $2.50
- Analyst Decision
- ELVN Strong Buy
- BAK Hold
- Analyst Count
- ELVN 5
- BAK 2
- Target Price
- ELVN $41.20
- BAK $4.40
- AVG Volume (30 Days)
- ELVN 399.0K
- BAK 1.5M
- Earning Date
- ELVN 11-12-2025
- BAK 11-10-2025
- Dividend Yield
- ELVN N/A
- BAK N/A
- EPS Growth
- ELVN N/A
- BAK N/A
- EPS
- ELVN N/A
- BAK N/A
- Revenue
- ELVN N/A
- BAK $14,266,076,929.00
- Revenue This Year
- ELVN N/A
- BAK $2.44
- Revenue Next Year
- ELVN $20.05
- BAK $9.90
- P/E Ratio
- ELVN N/A
- BAK N/A
- Revenue Growth
- ELVN N/A
- BAK 10.48
- 52 Week Low
- ELVN $13.30
- BAK $2.32
- 52 Week High
- ELVN $29.79
- BAK $6.36
- Technical
- Relative Strength Index (RSI)
- ELVN 49.61
- BAK 41.56
- Support Level
- ELVN $21.08
- BAK $2.35
- Resistance Level
- ELVN $22.36
- BAK $2.49
- Average True Range (ATR)
- ELVN 1.00
- BAK 0.11
- MACD
- ELVN 0.04
- BAK 0.02
- Stochastic Oscillator
- ELVN 43.98
- BAK 53.03
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.